Lenvima and Benicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenvima (lenvatinib mesylate) and Benicar (olmesartan medoxomil). Common drug interactions include alopecia among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Lenvima and Benicar. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lenvima?

Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.



On Aug, 06, 2026

18 people who take Lenvima and Benicar together, and have interactions are studied.

Lenvima and Benicar drug interactions.

What are the common drug interactions of Lenvima and Benicar, by gender? *:

female:

  1. Alopecia (absence of hair from areas of the body)
  2. Diarrhoea
  3. Fatigue (feeling of tiredness)
  4. Headache (pain in head)
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Colitis (inflammation of colon)
  7. Abdominal pain upper
  8. Bacterial infection
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Drug ineffective

male:

  1. Decreased appetite
  2. Weight decreased
  3. Stomatitis (inflammation of mucous membrane of mouth)
  4. Vomiting
  5. Blood glucose increased
  6. Cardiac failure
  7. Chapped lips (cracking, fissuring, and peeling of the skin f lip)
  8. Feeding disorder (when children refuse to eat certain food groups)
  9. Glossodynia (a burning or painful sensation in the tongue)
  10. Lip exfoliation

What are the common drug interactions of Lenvima and Benicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Sepsis (a severe blood infection that can lead to organ failure and death)

60+:

  1. Stomatitis (inflammation of mucous membrane of mouth)
  2. Fatigue (feeling of tiredness)
  3. Drug ineffective
  4. Dry mouth
  5. Dyspnoea (difficult or laboured respiration)
  6. Flatulence (flatus expelled through the anus)
  7. Glossodynia (a burning or painful sensation in the tongue)
  8. Haematochezia (passage of stools containing blood)
  9. Headache (pain in head)
  10. Muscle spasms (muscle contraction)

What are the existing conditions these people have? *

  1. Thyroid Cancer: 8 people, 44.44%
  2. Renal Cell Carcinoma (a kidney cancer): 8 people, 44.44%
  3. Metastases To Lung (cancer spreads to lung): 1 person, 5.56%
  4. Metastases To Liver (cancer spreads to liver): 1 person, 5.56%
  5. Endometrial Cancer: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lenvima and Benicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lenvima and Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lenvima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenvima and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lenvatinib mesylate and olmesartan medoxomil (the active ingredients of Lenvima and Benicar, respectively), and Lenvima and Benicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: